Novartis expands recall of heartburn meds to U.S. after finding carcinogen

Novartis expands recall of heartburn meds to U.S. after finding carcinogen

STAT Plus: Novartis expands recall of heartburn meds to U.S. after finding carcinogen

By ED SILVERMAN

FABRICE COFFRINI/AFP/GETTY IMAGES

A Novartis spokesman says that testing found NDMA “above levels established by the Food and Drug Administration in batches” of its capsules.

READ MORE